Mount Sinai School of Medicine is taking steps to establish itself among the best medical schools in the nation. The university is developing the second phase of a strategic plan authored by the Dean, Denis S. Charney. Currently the school is ranked 18th by US News and World Report, and is making an active attempt to become a global leader in medical research.
The campus gained its prestigious status with the help of a strategic plan that has helped incoming grants double over the last six years. $2.25 Billion was allocated to various medical research programs. This included funding for the ongoing construction of a 550,000 square foot Center for Science and Medicine. Six floors in the building will be strictly dedicated to laboratory space, with the idea to have a better understanding of obesity, heart disease, asthma, and other conditions.
Because the strategic plan has been so successful, Mount Sinai is in the midst of designing another plan that will explore the diseases that threaten humans the most. Researchers will focus primarily on the following:
- Cancer
- Cardiovascular disease
- Virology/vaccines
- Neurological disorders
(Image of Dennis S. Charney, M.D. courtesy of MSSM)
In this plan, Dennis S. Charney, M.D. relays an underlining theme of “Going From Very Good to Great.” Basic themes of this plan aims to do the following:
- Attract leaders and pioneers from within the biomedical industry who are open and flexible to the rapidly changing technical climate of the 21st century.
- Create research teams with an emphasis on collaboration and interdisciplinary study.
- Move up the scale among the top 20 NIH funded medical schools in the nation.
This post was created by Biotechnology Calendar, Inc., a full service event planning and marketing company, dedicated to connecting researchers with the tools and solutions they need. To network with laboratory professionals on campus at Mount Sinai, participate at the BioResearch Product Faire™ Event on October 18, 2011.
